Results 191 to 200 of about 92,770 (362)
Development of substituted 2-(4-(sulfonyl)piperazin-1-yl)quinazoline molecular hybrids as a new class of antimalarials. [PDF]
Madhav H +9 more
europepmc +1 more source
ABSTRACT The present study assessed the leishmanicidal activity of 4‐nerolidylcatechol (4‐NC) (1) isolated from Piper peltatum leaves against promastigotes and amastigotes of Leishmania amazonensis, L. braziliensis, and L. infantum. The plant was fractionated, leading to the isolation and chemical identification of 4‐NC (1). Biochemical techniques were
Fabiana Brusco Lorenzetti +8 more
wiley +1 more source
Accessibility to antimalarials in Spanish hospitals: analysis of a national survey. [PDF]
Bretones-Pedrinaci JI +4 more
europepmc +1 more source
Crystal structure of a quinolone derivative with antimalarial activity [PDF]
M.V. Capparelli +2 more
openalex +1 more source
ABSTRACT Quinoxaline is an aza‐heterocycle found in some bioactive compounds. Thus, to enhance the pharmacological scope of this nucleus, we report a series of 19 acetamides decorated with a quinoxaline core. The synthesis involved the linkage of previously constructed bromoacetamides and hydroxyphenyl quinoxalines via an SN2 reaction. The first series
Cesar E. Tovar‐Roman +2 more
wiley +1 more source
Artemether-lumefantrine versus pyronaridine-artesunate for the treatment of malaria in patients with mild to moderate COVID-19 in Kenya and Burkina Faso: a randomised open-label trial (MALCOV). [PDF]
Tangara B +30 more
europepmc +1 more source
Erratum to Use newer antimalarials selectively to delay plasmodial resistance [PDF]
Adis Editorial
openalex +1 more source
A link between poor quality antimalarials and malaria drug resistance?
P. Newton, C. Caillet, P. Guérin
semanticscholar +1 more source

